Publicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (17)

2021

  1. Scoring balloon predilation before bioresorbable vascular scaffold implantation in patients with in-stent restenosis: the RIBS VI 'scoring' study

    Coronary artery disease, Vol. 32, Núm. 2, pp. 96-104

2020

  1. Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR)

    International Journal of Cardiology, Vol. 299, pp. 49-55

  2. Lithotripsy-Facilitated Transfemoral Access for Transcatheter Aortic Valve Replacement

    CardioVascular and Interventional Radiology

2019

  1. Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement

    Journal of the American College of Cardiology, Vol. 74, Núm. 5, pp. 631-641

  2. Self-expanding transcatheter aortic valve implantation for degenerated Mitroflow bioprosthesis: Early outcomes

    International Journal of Cardiology, Vol. 287, pp. 53-58

2018

  1. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents

    JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991

2017

  1. Bioresorbable Vascular Scaffolds for Patients With In-Stent Restenosis: The RIBS VI Study

    JACC: Cardiovascular Interventions, Vol. 10, Núm. 18, pp. 1841-1851

  2. Shifting transcatheter aortic valve implantation to low-risk patients: A pilgrimage with no shortcuts

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 3, Núm. 4, pp. 258-261

  3. Usefulness of Drug-Eluting Balloons for Bare-Metal and Drug-Eluting In-Stent Restenosis (from the RIBS IV and V Randomized Trials)

    American Journal of Cardiology, Vol. 119, Núm. 7, pp. 983-990

2016

  1. Comparison of 1-Year Outcome in Patients with Severe Aorta Stenosis Treated Conservatively or by Aortic Valve Replacement or by Percutaneous Transcatheter Aortic Valve Implantation (Data from a Multicenter Spanish Registry)

    American Journal of Cardiology, Vol. 118, Núm. 2, pp. 244-250

  2. Comparison of the Efficacy of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients with In-Stent Restenosis (from the RIBS IV and v Randomized Clinical Trials)

    American Journal of Cardiology, Vol. 117, Núm. 4, pp. 546-554

2015

  1. Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)

    EuroIntervention, Vol. 11, Núm. 3, pp. 336-342

2013

  1. In-hospital and mid-term predictors of mortality after transcatheter aortic valve implantation: Data from the Tavi national registry 2010-2011

    Revista Espanola de Cardiologia, Vol. 66, Núm. 12, pp. 949-958

2006

  1. Implante directo del stent en el infarto agudo de miocardio. Estudio DISCO 3

    Revista Espanola de Cardiologia, Vol. 59, Núm. 3, pp. 217-224

  2. Value of the American College of Cardiology/American Heart Association angiographic classification of coronary lesion morphology in patients with in-stent restenosis: Insights from the Restenosis Intra-stent Balloon angioplasty versus elective Stenting (RIBS) randomized trial

    American Heart Journal, Vol. 151, Núm. 3, pp. 681.e1-681.e9

2005

  1. Características y mortalidad del infarto agudo de miocardio tratado con intervencionismo coronario percutáneo primario en España. Resultados del Registro TRIANA 1 (TRatamiento del Infarto Agudo de miocardio eN Ancianos)

    Revista Espanola de Cardiologia, Vol. 58, Núm. 4, pp. 341-350

2003

  1. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis

    Journal of the American College of Cardiology, Vol. 42, Núm. 5, pp. 796-805